BiotechTube
Healgen Scientific

Healgen Scientific

Houston, United States· Est.
healgen.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $47M

Overview

Healgen Scientific is a privately held, commercial-stage diagnostics company with a global footprint, specializing in rapid tests and comprehensive IVD solutions. Its core business model revolves around developing, manufacturing, and distributing FDA-cleared diagnostic tests, with a strong focus on infectious diseases (like COVID-19/Flu) and toxicology (including fentanyl and multi-drug panels). The company is revenue-generating, supported by an extensive partner network, in-house manufacturing, and a diverse pipeline that addresses urgent public health needs from workplace safety to women's health.

Infectious DiseaseToxicologyFertility & Women's HealthOncologyCardiovascularMetabolismAnimal Health

Technology Platform

Multi-platform diagnostics developer utilizing Rapid Lateral-Flow (RLF), Fluorescent Immunoassay (FIA), Western Blot, Biochemistry, and Molecular Diagnostics (FISH, Flow Cytometry, LAMP, PCR).

Funding History

2
Total raised:$47M
Series B$32M
Series A$15M

Opportunities

Significant growth exists in the expanding OTC/self-testing market, driven by consumer health empowerment.
The ongoing opioid crisis and mandated workplace drug testing create sustained demand for advanced toxicology panels, including fentanyl and oral fluid detection.
Diversification into molecular diagnostics and women's health opens higher-margin market segments.

Risk Factors

Revenue is exposed to the decline in pandemic-driven COVID-19 test demand.
The company operates in a highly competitive and price-sensitive diagnostics market against larger, well-capitalized players.
Regulatory hurdles and potential reimbursement challenges for new tests could delay market access and impact profitability.

Competitive Landscape

Healgen competes in a crowded global IVD market against giants like Abbott, QuidelOrtho, Roche, and BD in rapid testing, and numerous specialized toxicology companies. Its differentiation lies in its broad portfolio spanning human and animal health, multi-technology platform approach, and focus on obtaining FDA clearances for professional and OTC use.

More companies in Diagnostics & Precision Medicine →More companies in United States →